Cresco Labs (CRLBF) Income towards Parent Company (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Income towards Parent Company came in at -$13.3 million in Q1 2026, up 8.04% YoY from -$12.3 million in Q1 2025, and up 84.45% on a QoQ basis from -$85.3 million in Q4 2025.
Cresco Labs (CRLBF) Income towards Parent Company (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Income towards Parent Company data on file, last reported at -$13.3 million in Q1 2026.
- Quarterly Income towards Parent Company rose 8.04% year-over-year to -$13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$132.2 million (down 79.26% YoY) and the FY2025 annual result came in at -$140.0 million, down 131.52% from the prior year.
- Income towards Parent Company grew to -$13.3 million in Q1 2026, from -$85.3 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $27.4 million in Q1 2022 to a low of -$161.3 million in Q4 2022.
- A 5-year average of -$32.0 million and a median of -$14.4 million in 2025 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2024 — Income towards Parent Company jumped 115.22% — and 2025, when it slumped 1604.87%.
- Tracing CRLBF's Income towards Parent Company over 5 years: stood at -$161.3 million in 2022, then soared by 101.63% to $2.6 million in 2023, then soared by 115.22% to $5.7 million in 2024, then tumbled by 1604.87% to -$85.3 million in 2025, then jumped by 84.45% to -$13.3 million in 2026.
- The last three Income towards Parent Company figures came in at -$13.3 million (Q1 2026), -$85.3 million (Q4 2025), and -$17.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.27 Mn |
| Dec 31, 2025 | -85.34 Mn |
| Sep 30, 2025 | -17.29 Mn |
| Jun 30, 2025 | -16.33 Mn |
| Mar 31, 2025 | -14.43 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | -10.54 Mn |
| Jun 30, 2024 | -54.46 Mn |
| Mar 31, 2024 | -5.51 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | -115.57 Mn |
| Jun 30, 2023 | -36.53 Mn |
| Mar 31, 2023 | -26.05 Mn |
| Dec 31, 2022 | -161.34 Mn |
| Sep 30, 2022 | -9.79 Mn |
| Jun 30, 2022 | -13.54 Mn |
| Mar 31, 2022 | 27.38 Mn |
| Dec 31, 2021 | -624.46 Mn |
| Sep 30, 2021 | -270.65 Mn |
| Jun 30, 2021 | 4.83 Mn |